Literature DB >> 8449827

Random process of metastasis and generation of heterogeneity in a mouse sarcoma line.

O Niwa1, Y Enoki, S Sadamoto, K Kamiya, K Yokoro.   

Abstract

The process of metastasis was analyzed in 505-05-01 cells, an established line of a methyl-cholanthrene-induced mouse sarcoma, by tagging the cells with the pSV2neo plasmid. A dominant clone was identified which, upon transplantation together with other clones, overgrew tumors in the kidney capsule. However, when this clone was transplanted in a mouse collaterally with recessive clones, both clones grew at the same rate and metastasized to the lung at an equal frequency. This suggests that the process of metastasis in this particular sarcoma line is stochastic, the dominant population having a better chance to colonize to the lung. The dominant neomycin-resistant clone was transfected with another marker plasmid, pY3, which confers resistance to hygromycin. Results of mixed inoculation of 9 independently isolated clones revealed the hierarchy of dominance among clones. This indicated the existence of heterogeneity within the parental clone. Upon mixed inoculation with hygromycin-resistant clones, the parental clone overgrew in the tumors. This indicated that some clone had changed its phenotype to become less aggressive. Thus, the direction of phenotypic drift in vitro seems to be random in terms of behavior in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449827      PMCID: PMC5919039          DOI: 10.1111/j.1349-7006.1993.tb02782.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

Review 1.  The significance of biological heterogeneity.

Authors:  H Rubin
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

2.  Tumor cells transfected with the neomycin resistance gene (neo) contain unique genetic markers useful for identification of tumor recurrence and metastasis.

Authors:  C Talmadge; Y Tanio; A Meeker; J Talmadge; B Zbar
Journal:  Invasion Metastasis       Date:  1987

Review 3.  Mechanisms of tumor progression.

Authors:  P C Nowell
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

4.  Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells.

Authors:  K Blochlinger; H Diggelmann
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

5.  Production of large amounts of hydrogen peroxide by human tumor cells.

Authors:  T P Szatrowski; C F Nathan
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

6.  Cancer metastasis is selective or random depending on the parent tumour population.

Authors:  J E Talmadge; I J Fidler
Journal:  Nature       Date:  1982-06-17       Impact factor: 49.962

7.  Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.

Authors:  Y Kodama; T Seyama; K Kamiya; K Yokoro
Journal:  J Natl Cancer Inst       Date:  1982-09       Impact factor: 13.506

8.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Genetic tagging of tumor cells with retrovirus vectors: clonal analysis of tumor growth and metastasis in vivo.

Authors:  B Korczak; I B Robson; C Lamarche; A Bernstein; R S Kerbel
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

10.  Overexpression and amplification of the c-myc gene in mouse tumors induced by chemicals and radiations.

Authors:  O Niwa; Y Enoki; K Yokoro
Journal:  Jpn J Cancer Res       Date:  1989-03
View more
  1 in total

1.  p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas.

Authors:  K Shimokado; H Watanabe; M Sumii; K Miyagawa; K Kamiya; K Dohi; O Niwa
Journal:  Jpn J Cancer Res       Date:  1998-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.